Even more on the "New Horizons in Oral Medicat... - CLL Support

CLL Support

22,985 members39,473 posts

Even more on the "New Horizons in Oral Medication For CLL Treatment"

HAIRBEAR_UK profile image
HAIRBEAR_UKFounder Admin
2 Replies

Andrew Schorr has just posted his latest video interview and broadcast on latest developments coming out of ASH.

“Dr. Steven Rosen, from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University in Chicago, expresses his excitement about advancements in blood cancer treatments presented at the 2012 American Society of Hematology annual meeting. Dr. Rosen explains one of the key factors for determining the best treatment course is understanding the genetics of each individual's cancer. As survivorship increases, the paradigm of care is shifting to focus on long term disease management and maintaining quality of life.”

youtube.com/watch?v=M71yOxh...

patientpower.info/video/an-...

Brian Koffman has also posted the second video of in his series of three that make up his interview of Dr Pagel bkoffman.blogspot.co.uk/ .

Written by
HAIRBEAR_UK profile image
HAIRBEAR_UK
Founder Admin
To view profiles and participate in discussions please or .
Read more about...
2 Replies
jangreen profile image
jangreen

Hi I have found these videos bring great hope but when I saw my consultant today he was lukewarm about ASH. So we will wait and see.

HAIRBEAR_UK profile image
HAIRBEAR_UKFounder Admin

Yes they do, I guess time will tell. Hope all went well for you today

Not what you're looking for?

You may also like...

ASH 2013: Dr. John Pagel Speculates on the Future of CLL Therapies including the late breaking data on Idelalisib

ASH 2013: Dr. John Pagel Speculates on the Future of CLL (chronic lymphocytic leukemia) Therapies...

Chronic Lymphocytic Leukaemia: "an overview" & A look at the future of CLL treatment: "New treatment options". Dr George Follows - June 2014

The following video/webcasts were produced in Cambridge June 2014 from talks by Dr George Follows...

EHA 2016: Professor Hallek on the Unmet Needs in CLL

Today in the 2016 Conference Coverage section of the CLL Society website, we’ve posted an interview...

ASH 2015: Dr. John M Pagel on the Problems with Idelalisib as Frontline Therapy in CLL

It has been a while since I posted an interview on my blog first instead of the CLL Society...

Dr Sharman on "Choosing first therapy in CLL"

Dr. Sharman briefly discusses the whys of the rather unique Watch and Wait 'treatment' decision for...